04 May 2022 New study led by Memorial Sloan Kettering Cancer Center (NY, US) shows Idylla™ GeneFusion Assay enables more rapid screening of targetable fusions compared to routine methods Member news
03 May 2022 reMYND’s novel Alzheimer program reports excellent brain exposure and safety profile in Phase 1; transitioning into Phase 2a Member news
29 Apr 2022 Flanders launches new tech ecosystem platform to connect start-ups to investors Member news
27 Apr 2022 Kantify and I-Stem Use Artificial Intelligence to discover a promising therapy against a rare disease Member news
26 Apr 2022 Digital histopathology company launches integrated platform capable of accelerating drug development Member news
26 Apr 2022 Mithra CDMO announces collaboration with MedinCell for the development of injectable products for Malaria and transplant rejection Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
